Showing posts with label Health. Show all posts
Showing posts with label Health. Show all posts

Monday


About half-a-million residents of Surulere are reportedly at the risk of a looming epidemic, expect the state government finds a quick solution to a threatening environmental problem.

Vanguard newspaper reports that, no fewer than 500,000 residents of Iponri Low-Cost Housing Estate, Surulere Local Government Area, Lagos State, on Sunday appealed to the Lagos State Government to save their lives from epidemic that was looming there.

The sewage plant that usually drains dirty water from the soak-away of more than 400 housing units with 500,000 residents had been disconnected by Eko Disco (EKEDC) due to unpaid bills.

They said that the non-functioning of the sewage plant had resulted into flooding of the estate by dirty water from the soak away, thus spreading stench odour in the area.

Mr Abdul-Rasak Osho, President, Iponri Housing Estate Residents’ Association, told NAN that the sewage plant constructed by the Lagos State Government was being maintained by the Ministry of the Environment.

“The residents noticed that the sewage plant stopped working about three months ago. We met the engineer-in-charge who told us that the power supply to the plant had been disconnected because LASG owed the EKEDC.

“We bought diesel for them to power the plant but it was exhausted within just five hours. We have appealed to EKEDC to restore the power supply but it said not until the Lagos State Government must have paid what it owed the company.

‘The sewage plant has been under the government care since we bought flats in this estate and government has not told us that it can no longer maintain it.

“Presently, the dirty water has flooded everywhere in the estate. We cannot even pass some routes now because of the flood,” he said.

Osho appealed to the state government to offset the bill so that EKEDC would restore power supply to the sewage plant and safe the estate from the impending epidemic.

Mr Francis Odukoya, the Secretary-General of the association, said that the association had written several letters to the state Ministry of the Environment on the problem.

However, the state government had not replied to any of our correspondence.

“We have written about four letters to the Honourable Commissioner for the Environment as I am speaking to you now.

“They built the sewage plant for the estate and they have been servicing it for us for more than 30 years now, they should not relent on their efforts.

“They should come to our rescue before the residents of the estate start to contact disease because this odour is terrible,” he said.

Mrs Alake Oshodi, an old widow, living in Flat 103 in the estate, told NAN that one of her granddaughters developed illness recently and had been admitted to a private hospital.

“I’m sure the illness was as a result of this dirty water and bad odour in the estate, the government should help us before we all contact cholera,” she cried.

Correspondent could not speak with the engineer in charge of the sewage plant because the main entrance to the place was locked.

Also, none of the officials of the Ministry of the Environment was ready to speak on the issue.

They said they were not permitted to speak to the press.

Friday



A new hydrogel-based condom that contains antioxidants has been invented by a team of Indian-American scientists at the Texas A&M University Health Science Center. Not only does it contain plant-based antioxidants, which kills the HIV-virus in case of condom breakage but it also uses antioxidants to enhance pleasure. Experts say it is the new big player to join the fight against AIDS



"We are not only making a novel material for condoms to prevent the HIV infection, but we are also aiming to eradicate this infection if possible. Supercondom could help fight against HIV infection and may as well prevent unwanted pregnancy or sexually transmitted diseases. If we succeed, it will revolutionize the HIV prevention initiative"Choudhury, the lead researcher and assistant professor at the Texas A&M Health Science Center's Irma Lerma Rangel College of Pharmacy, said The researchers hope to test the condom within the next six months and then get it released for general usage.



Tuesday



Happy November! Upon us are some of the best times of the year: the holidays!

Crisp air, good spirits, time off (!!!) and delicious food that starts with what’s in season. So what exactly should you be shopping for this month as you stroll through your local farmers market and/or grocery store?

Here is your November seasonal fruits and vegetables guide:

Apples
Artichokes
Beets
Brussels Sprouts
Grapes
Kiwi

Mushrooms
Oranges
Pears
Peppers
Persimmons
Pomegranates
Potatoes
Pumpkin
Radishes
Winter Squash

Friday



Turing Pharmaceuticals, a months-old biotech startup that is largely financed by its 32-year-old founder and CEO Martin Shkreli, sparked widespread outrage last month. The reason: shortly after paying $55 million for a 62-year-old drug called Daraprim that’s prescribed for toxoplasmosis and other types of infections, Turing repriced the drug from $13.50 per pill to a stunning $750 per pill.

Shkreli was wholly unapologetic about the move, too, tweeting, when asked how he was able to sleep at night, that he uses Ambien. We’d covered his somewhat stunning reaction to critics here.

Now, Shkreli — a former hedge fund manager who was ousted from his last company, Retrophin — is seemingly about to get a taste of his own medicine. Yesterday, Imprimis Pharmaceuticals, a publicly traded, San Diego-based specialty pharmaceutical company, announced that it has created a customizable alternative to Daraprim that costs roughly $1 per pill.

“While we respect Turing’s right to charge patients and insurance companies whatever it believes is appropriate, there may be more cost-effective compounded options for medications, such as Daraprim, for patients, physicians, insurance companies and pharmacy benefit managers to consider,” the company said in its statement.

Imprimis’ new compound is a combination of pyrimethamine along with another generic drug called leucovorin, a form of folic acid. It isn’t FDA-approved, though its specific ingredients are FDA-approved. As a result, reports the San Diego Union-Tribune, it can be sold through a doctor’s prescription to a specific individual.

Shkreli had founded Turing earlier this year, closing a $90 million Series A round in August that he reportedly led himself. It also included several other unnamed “preeminent institutional equity investors,” according to a statement.


Turing also took on some senior secured debt, which is unusual and may explain why it was eager to alter the pricing of Daraprim.

After coming under fire from critics, Shkreli told ABC News last month that, “We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit.”

As of two weeks ago, that still had not happened.

In the meantime, Turing posted an announcement earlier today, saying the FDA has cleared the way for the clinical trial of another of its drugs, one that treats epileptic encephalopathies

Blog Archive

Followers

Featured Posts

Recent Post

Watch CHUCKYSTV - #RANDOMROOMRAP

click and enjoy #RandomRoomRap #RRR FOLLOW THE TAG ON TWITTER, and subscribe to our channel on youtube.com/chuckysblog

Posted by Chucky's blog on Sunday, July 26, 2015

Follow on Twitter

Like us on Facebook

Live Traffic